AETHLON MEDICAL INC

AEMD · Nasdaq · SIC 3841: Surgical & Medical Instruments & Apparatus · Market Cap: $0.0B · 9 employees
385
SEC Filings
$3.07
Close 2026-05-27
9
Employees

Business Summary

Aethlon Medical, Inc. is a clinical-stage medical therapeutic company developing the Hemopurifier (HP), a lectin-based immunotherapeutic device designed to remove harmful extracellular vesicles (EVs) and enveloped viruses from biological fluids. The FDA has granted the Hemopurifier Breakthrough Device designation for advanced/metastatic cancer and life-threatening viruses. The company is conducting oncology clinical trials in Australia and pursuing approval in India.

Latest Stock Quote

AEMD 2026-05-27 $3.07 O:$2.83 H:$3.18 L:$2.65 Vol:16.0M VWAP:$3.1418
origin leaf: c3334df580e35d06524d1fa8911bca1d17996c5b46d79fb65bb8dd0cd1597723

Next Earnings

Q2 FY2026 — expected 2026-09-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-06-262025-03-310001683168-25-004780EDGAR76K words
2024-06-272024-03-310001683168-24-004530EDGAR—
2023-06-282023-03-310001683168-23-004487EDGAR—
2022-06-282022-03-310001683168-22-004641EDGAR—
2021-06-242021-03-310001683168-21-002707EDGAR—
2020-06-252020-03-310001683168-20-002070EDGAR—
2019-07-012019-03-310001683168-19-002070EDGAR—
2018-06-082018-03-310001683168-18-001643EDGAR—
2017-06-282017-03-310001683168-17-001671EDGAR—
2016-06-292016-03-310001019687-16-006800EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-122025-12-310001683168-26-000964EDGAR19K words
2025-11-122025-09-300001683168-25-008271EDGAR—
2025-08-132025-06-300001683168-25-006049EDGAR—
2025-02-122024-12-310001683168-25-000960EDGAR—
2024-11-132024-09-300001683168-24-007984EDGAR—
2024-08-142024-06-300001683168-24-005708EDGAR—
2024-02-142023-12-310001683168-24-000993EDGAR—
2023-11-142023-09-300001683168-23-008142EDGAR—
2023-08-102023-06-300001683168-23-005524EDGAR—
2023-02-132022-12-310001683168-23-000822EDGAR—
2022-11-142022-09-300001683168-22-007744EDGAR—
2022-08-092022-06-300001683168-22-005474EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-170001683168-26-001887EDGAR0K words
2026-02-230001683168-26-001259EDGAR—
2026-02-120001683168-26-000959EDGAR—
2026-01-260001683168-26-000528EDGAR—
2025-12-080001683168-25-008953EDGAR—
2025-11-120001683168-25-008257EDGAR—
2025-11-060001683168-25-008001EDGAR—
2025-10-220001683168-25-007719EDGAR—
2025-10-160001683168-25-007586EDGAR—
2025-09-120001683168-25-006917EDGAR—

385 total filings indexed. 353 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

MMM — 3M CO ARAY — ACCURAY INC ALUR — ALLURION TECHNOLOGIES, INC. ANGO — ANGIODYNAMICS INC AORT — ARTIVION, INC. RCEL — AVITA Medical, Inc. ADGM — Adagio Medical Holdings, Inc. ATEC — Alphatec Holdings, Inc.

Tags

oncology-(advanced/metastatic-cancer) life-threatening-viral-infections organ-transplantation medical-devices fda-breakthrough-device-designation fda-investigational-device-exemption-(ide) good-manufacturing-practices-(gmp)

Company Identity

CIK0000882291
TickerAEMD
ExchangeNasdaq
SIC3841: Surgical & Medical Instruments & Apparatus
IncorporatedNV
HeadquartersSan Diego, California
Websitehttps://www.aethlonmedical.com
Listed1998-11-06

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 8a38b06b5078763e3dbba2939d5b69c434095456f4c4927c4fa901197fa78a98
parent: c574b57e8a7e578c83dd46123eb2ddfdfa5f801e7e199cfee07b98879c8e5508
content hash: d9dad838af05e5f885162445ca0d0181a6568151fb2271646dfb00559e41421f
signed: 2026-06-02T19:00:05.665Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf